Larry Glass

Title: Larry Glass: Innovator in Autism Spectrum Disorder Treatment

Introduction

Larry Glass is a notable inventor based in Takoma Park, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of Autism Spectrum Disorders (ASD). His innovative approach focuses on utilizing specific compounds to address the challenges associated with these conditions.

Latest Patents

Larry Glass holds a patent for the treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate. This invention provides compounds, compositions, and methods for treating Autism Spectrum Disorders, including Autism, Autistic Disorder, Asperger Syndrome, Childhood Disintegrative Disorder, Pervasive Developmental Disorder—Not Otherwise Specified (PDD-NOS), Fragile X Syndrome, and Rett Syndrome. The compositions include various formulations such as water-soluble formulations, water-in-oil micro-emulsions, and orally administered gels. These compounds can be administered through multiple routes and have shown effectiveness in treating neurodegeneration and promoting neurological function.

Career Highlights

Larry Glass is associated with Neuren Pharmaceuticals Limited, where he continues to develop and refine his innovative treatments. His work has the potential to significantly impact the lives of individuals affected by Autism Spectrum Disorders.

Collaborations

Larry collaborates with esteemed colleagues, including Michael John Bickerdike and Michael Frederick Snape, to advance research and development in this critical area of healthcare.

Conclusion

Larry Glass is a pioneering inventor whose work in treating Autism Spectrum Disorders showcases the potential of innovative medical solutions. His contributions are vital in the ongoing quest to improve the quality of life for those affected by these conditions.